HOME >> BIOLOGY >> NEWS
Anammox bacteria produce nitrogen gas in oceans' snackbar

This release is also available in German

Thirty to fifty percent of the global conversion of nutrients to nitrogen gas occurs in these areas. In 'The Proceedings of the National Academy of Science of the United States (PNAS)' of Tuesday 19 April, researchers from Bremen and Nijmegen state that this conversion is not carried out by denitrifying bacteria, as was believed for decades, but by anammox bacteria. Nitrogen compounds act as fertilizers and are the ecological basis for any lifeform on earth as these compounds limit the overall growth rate.

The researchers discovered this type of bacteria for the first time a few years ago in the oxygen poor Black Sea and now also in the open ocean. This discovery has major consequences for our understanding of the global nitrogen cycle. The Benguela current system leads to upwelling of nutrient-rich cold water off the coast of Namibia and acts as a kind of snackbar in the tropical ocean, which is visited by many animals including giant whales. The newly discovered anammox bacteria remove ammonium from the ocean, which as a result can not be taken up anymore by other organisms. Algae and cyanobacteria only partly succeed in fixing the released nitrogen gas to form new nutrients that can be fed into the nutrient cycle again.

In the article in PNAS, researchers from the Max Planck Institute for Marine Microbiology (Bremen, Germany) and the Institute of Water and Wetland Research (IWWR) of the Radboud University of Nijmegen show for the first time that anammox bacteria are present in the Atlantic ocean in oxygen poor waters at ~100 m depth. The number and activity of anammox bacteria present at this depth is sufficient to remove the ammonium that rises up from deeper waters and the seafloor. A unique combination of microbiological methods involving high resolution nutrient profiles, experiments with stable isotope labeled nut
'"/>

Contact: Dr. Marcel Kuypers
mkuypers@mpi-bremen.de
49-421-202-8634
Max-Planck-Gesellschaft
19-Apr-2005


Page: 1 2 3

Related biology news :

1. In limiting life span, study finds booming bacteria innocent
2. Cornell scientists link E. coli bacteria to Crohns disease
3. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
4. Researchers watch antibiotics, bacteria meet at atomic level
5. A new plant-bacterial symbiotic mechanism promising
6. Piecing together the cyanobacteria puzzle
7. New research shows vaginal bacteria vary among healthy women, need customized treatment
8. New way to target and kill antibiotic-resistant bacteria found
9. UCF professor finds bacterial pathogen may be key to understanding cancer development
10. Helping chlorine-eating bacteria clean up toxic waste
11. Researchers discover acquired DNA key to certain bacterial infection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anammox bacteria produce nitrogen gas oceans snackbar

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: